chr14-104701470-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001426862.1(INF2):​c.105C>T​(p.Pro35Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.978 in 1,600,582 control chromosomes in the GnomAD database, including 765,311 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.98 ( 73251 hom., cov: 36)
Exomes 𝑓: 0.98 ( 692060 hom. )

Consequence

INF2
NM_001426862.1 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: -1.64

Publications

16 publications found
Variant links:
Genes affected
INF2 (HGNC:23791): (inverted formin 2) This gene represents a member of the formin family of proteins. It is considered a diaphanous formin due to the presence of a diaphanous inhibitory domain located at the N-terminus of the encoded protein. Studies of a similar mouse protein indicate that the protein encoded by this locus may function in polymerization and depolymerization of actin filaments. Mutations at this locus have been associated with focal segmental glomerulosclerosis 5.[provided by RefSeq, Aug 2010]
INF2 Gene-Disease associations (from GenCC):
  • Charcot-Marie-Tooth disease dominant intermediate E
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Orphanet
  • focal segmental glomerulosclerosis 5
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • familial idiopathic steroid-resistant nephrotic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 14-104701470-C-T is Benign according to our data. Variant chr14-104701470-C-T is described in ClinVar as Benign. ClinVar VariationId is 261603.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.64 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.987 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001426862.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
INF2
NM_022489.4
MANE Select
c.105C>Tp.Pro35Pro
synonymous
Exon 2 of 23NP_071934.3
INF2
NM_001426862.1
c.105C>Tp.Pro35Pro
synonymous
Exon 2 of 23NP_001413791.1
INF2
NM_001426863.1
c.105C>Tp.Pro35Pro
synonymous
Exon 2 of 23NP_001413792.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
INF2
ENST00000392634.9
TSL:5 MANE Select
c.105C>Tp.Pro35Pro
synonymous
Exon 2 of 23ENSP00000376410.4
INF2
ENST00000398337.8
TSL:1
c.105C>Tp.Pro35Pro
synonymous
Exon 2 of 5ENSP00000381380.4
INF2
ENST00000617571.5
TSL:1
n.105C>T
non_coding_transcript_exon
Exon 1 of 22ENSP00000483829.2

Frequencies

GnomAD3 genomes
AF:
0.980
AC:
149265
AN:
152248
Hom.:
73193
Cov.:
36
show subpopulations
Gnomad AFR
AF:
0.995
Gnomad AMI
AF:
0.997
Gnomad AMR
AF:
0.975
Gnomad ASJ
AF:
0.950
Gnomad EAS
AF:
1.00
Gnomad SAS
AF:
0.989
Gnomad FIN
AF:
0.963
Gnomad MID
AF:
0.937
Gnomad NFE
AF:
0.975
Gnomad OTH
AF:
0.970
GnomAD2 exomes
AF:
0.978
AC:
219351
AN:
224292
AF XY:
0.978
show subpopulations
Gnomad AFR exome
AF:
0.996
Gnomad AMR exome
AF:
0.982
Gnomad ASJ exome
AF:
0.957
Gnomad EAS exome
AF:
1.00
Gnomad FIN exome
AF:
0.962
Gnomad NFE exome
AF:
0.974
Gnomad OTH exome
AF:
0.968
GnomAD4 exome
AF:
0.978
AC:
1415694
AN:
1448216
Hom.:
692060
Cov.:
82
AF XY:
0.978
AC XY:
703233
AN XY:
719300
show subpopulations
African (AFR)
AF:
0.996
AC:
33104
AN:
33228
American (AMR)
AF:
0.981
AC:
42455
AN:
43296
Ashkenazi Jewish (ASJ)
AF:
0.954
AC:
24674
AN:
25868
East Asian (EAS)
AF:
1.00
AC:
38997
AN:
39000
South Asian (SAS)
AF:
0.988
AC:
83107
AN:
84142
European-Finnish (FIN)
AF:
0.962
AC:
49227
AN:
51156
Middle Eastern (MID)
AF:
0.949
AC:
5455
AN:
5746
European-Non Finnish (NFE)
AF:
0.977
AC:
1080188
AN:
1105932
Other (OTH)
AF:
0.977
AC:
58487
AN:
59848
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
2139
4278
6417
8556
10695
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21584
43168
64752
86336
107920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.980
AC:
149382
AN:
152366
Hom.:
73251
Cov.:
36
AF XY:
0.980
AC XY:
73034
AN XY:
74510
show subpopulations
African (AFR)
AF:
0.995
AC:
41404
AN:
41594
American (AMR)
AF:
0.975
AC:
14928
AN:
15314
Ashkenazi Jewish (ASJ)
AF:
0.950
AC:
3297
AN:
3472
East Asian (EAS)
AF:
1.00
AC:
5165
AN:
5166
South Asian (SAS)
AF:
0.989
AC:
4775
AN:
4830
European-Finnish (FIN)
AF:
0.963
AC:
10234
AN:
10628
Middle Eastern (MID)
AF:
0.935
AC:
275
AN:
294
European-Non Finnish (NFE)
AF:
0.975
AC:
66341
AN:
68040
Other (OTH)
AF:
0.971
AC:
2054
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
160
321
481
642
802
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
914
1828
2742
3656
4570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.975
Hom.:
154617
Bravo
AF:
0.982
Asia WGS
AF:
0.997
AC:
3468
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
7
not specified (7)
-
-
2
Focal segmental glomerulosclerosis 5 (2)
-
-
1
Charcot-Marie-Tooth disease dominant intermediate E (1)
-
-
1
Focal segmental glomerulosclerosis 5;C4302667:Charcot-Marie-Tooth disease dominant intermediate E (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.63
CADD
Benign
3.6
DANN
Benign
0.82
PhyloP100
-1.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=92/8
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4983530; hg19: chr14-105167807; COSMIC: COSV108150383; API